Breath ethane peaks during a single haemodialysis session and is associated with time on dialysis

Journal of Breath Research

Volumn 2, Issue 2, 2008, Pages

  Stevenson, K S ^a   Radhakrishnan, K ^a   Patterson, C S ^a   McMillan, L C ^b   Skeldon, K D ^a   Buist, L ^c   Padgett, M J ^a   Shiels, P G ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c WESTERN INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ETHANE;

ADULT; AGED; ARTICLE; BREATH ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; OXIDATIVE STRESS; PRIORITY JOURNAL; SAMPLING; SEX; SPECTROSCOPY; STATISTICAL SIGNIFICANCE; TIME; VASCULAR ACCESS;

EID: 80051601029     PISSN: 17527155     EISSN: 17527163     Source Type: Journal    
DOI: 10.1088/1752-7155/2/2/026004     Document Type: Article

References (51)

1. Dhalla N S, Temsah R M and Netticadan T 2000 Role of oxidative stress in cardiovascular diseases J. Hypertens. 18 655-73
2. Sies H 1997 Oxidative stress: oxidants and antioxidants Exp. Physiol. 82 291-5
3. Handelman G J 2000 Evaluation of oxidant stress in dialysis patients Blood Purif. 18 343-9
4. Handelman G J 2003 Current studies on oxidant stress in dialysis Blood Purif. 21 46-50
5. Wratten M L, Tetta C, Ursini F and Sevanian A 2000 Oxidant stress in hemodialysis: prevention and treatment strategies Kidney Int. Suppl. 76 S126-S32
6. Wratten M L, Galaris D, Tetta C and Sevanian A 2002 Evolution of oxidative stress and inflammation during hemodialysis and their contribution to cardiovascular disease Antioxid. Redox. Signal 4 935-44
7. Dursun E, Ozben T, Suleymanlar G, Dursun B and Yakupoglu G 2002 Effect of hemodialysis on the oxidative stress and antioxidants Clin. Chem. Lab Med. 40 1009-13
8. Dursun E, Dursun B, Suleymanlar G and Ozben T 2005 Effect of haemodialysis on the oxidative stress and antioxidants in diabetes mellitus 16 Acta Diabetol. 42 123-8
9. Cristol J P, Canaud B, Rabesandratana H, Gaillard I, Serre A and Mion C 1994 Enhancement of reactive oxygen species production and cell surface markers expression due to haemodialysis Nephrol. Dial. Transplant. 9 389-94
10. Descamps-Latscha B, Goldfarb B, Nguyen A T, Landais P, London G, Haeffner-Cavaillon N, Jacquot C, Herbelin A and Kazatchkine M 1991 Establishing the relationship between complement activation and stimulation of phagocyte oxidative metabolism in hemodialyzed patients: a randomized prospective study Nephron 59 279-85
11. Arvanitidou M, Spaia S, Katsinas C, Pangidis P, Constantinidis T, Katsouyannopoulos V and Vayonas G 1998 Microbiological quality of water and dialysate in all haemodialysis centres of Greece Nephrol. Dial. Transplant. 13 949-54
12. DeLeo F R, Renee J, McCormick S, Nakamura M, Apicella M, Weiss J P and Nauseef W M 1998 Neutrophils exposed to bacterial lipopolysaccharide upregulate NADPH oxidase assembly J. Clin. Invest 101 455-63
13. Morrow J D, Awad J A, Boss H J, Blair I A and Roberts L J 1992 Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids Proc. Natl Acad. Sci. USA 89 10721-5
14. Zwolinska D, Grzeszczak W, Kilis-Pstrusinska K, Szprynger K and Szczepanska M 2004 Lipid peroxidation and antioxidant enzymes in children with chronic renal failure Pediatr. Nephrol. 19 888-92
15. Maggi E, Bellazzi R, Gazo A, Seccia M and Bellomo G 1994 Autoantibodies against oxidatively-modified LDL in uremic patients undergoing dialysis Kidney Int. 46 869-76
16. Maggi E, Bellazzi R, Falaschi F, Frattoni A, Perani G, Finardi G, Gazo A, Nai M, Romanini D and Bellomo G 1994 Enhanced LDL oxidation in uremic patients: an additional mechanism for accelerated atherosclerosis? Kidney Int. 45 876-83
17. Descamps-Latscha B, Drueke T and Witko-Sarsat V 2001 Dialysis-induced oxidative stress: biological aspects, clinical consequences and therapy Semin. Dial. 14 193-9
18. Dale O, Bergum H, Lund T, Nilsen T, Aadahl P and Stenseth R 2003 A validated method for rapid analysis of ethane in breath and its application in kinetic studies in human volunteers Free Radic. Res. 37 815-21
19. Andreoni K A, Kazui M, Cameron D E, Nyhan D, Sehnert S S, Rohde C A, Bulkley G B and Risby T H 1999 Ethane: a marker of lipid peroxidation during cardiopulmonary bypass in humans Free Radic. Biol. Med. 26 439-45
20. Kazui M, Andreoni K A, Norris E J, Klein A S, Burdick J F, Beattie C, Sehnert S S, Bell W R, Bulkley G B and Risby T H 1992 Breath ethane: a specific indicator of free-radical-mediated lipid peroxidation following reperfusion of the ischemic liver Free Radic. Biol. Med. 13 509-15
21. Risby T H et al 1994 Evidence for free radical-mediated lipid peroxidation at reperfusion of human orthotopic liver transplants Surgery 115 94-101
22. Patterson C S, McMillan L C, Longbottom C, Gibson G M, Padgett M J and Skeldon K D 2007 Portable optical spectroscopy for accurate analysis of ethane in exhaled breath Meas. Sci. Technol. 18 1459-64
23. Patterson C S, McMillan L C, Stevenson K, Radhakrishnan K, Shiels P G, Padgett M J and Skeldon K D 2007 Dynamic study of oxidative stress in renal dialysis patients based on breath ethane measured by optical spectroscopy J. Breath Res. 1 026005
24. Beddhu S, Bruns F J, Saul M, Seddon P and Zeidel M L 2000 A simple comorbidity scale predicts clinical outcomes and costs in dialysis patients Am. J. Med. 108 609-13
25. Nathan C 1992 Nitric oxide as a secretory product of mammalian cells FASEB J. 6 3051-64
26. Davies K J 1987 Protein damage and degradation by oxygen radicals. I. general aspects J. Biol. Chem. 262 9895-901
27. Wolff S P and Dean R T 1986 Fragmentation of proteins by free radicals and its effect on their susceptibility to enzymic hydrolysis Biochem. J. 234 399-403
28. Klebanoff S J 1970 Myeloperoxidase: contribution to the microbicidal activity of intact leukocytes Science 169 1095-7
29. Libetta C, Zucchi M, Gori E, Sepe V, Galli F, Meloni F, Milanesi F and Dal Canton A 2004 Vitamin E-loaded dialyzer resets PBMC-operated cytokine network in dialysis patients Kidney Int. 65 1473-81
30. Todeschini M et al 2002 Effect of acetate-free biofiltration and bicarbonate hemodialysis on neutrophil activation Am. J. Kidney Dis. 40 783-93
31. Himmelfarb J, Lazarus J M and Hakim R 1991 Reactive oxygen species production by monocytes and polymorphonuclear leukocytes during dialysis Am. J. Kidney Dis. 17 271-6
32. Zwolinska D, Grzeszczak W, Szczepanska M, Kilis-Pstrusinska K and Szprynger K 2006 Lipid peroxidation and antioxidant enzymes in children on maintenance dialysis Pediatr. Nephrol. 21 705-10
33. Hoenich N A and Katopodis K P 2002 Clinical characterization of a new polymeric membrane for use in renal replacement therapy Biomaterials 23 3853-8
34. Rosenkranz A R, Templ E, Traindl O, Heinzl H and Zlabinger G J 1994 Reactive oxygen product formation by human neutrophils as an early marker for biocompatibility of dialysis membranes Clin. Exp. Immunol. 98 300-5
35. Morimoto H, Nakao K, Fukuoka K, Sarai A, Yano A, Kihara T, Fukuda S, Wada J and Makino H 2005 Long-term use of vitamin E-coated polysulfone membrane reduces oxidative stress markers in haemodialysis patients Nephrol. Dial. Transplant. 20 2775-82
36. Sela S, Shurtz-Swirski R, Cohen-Mazor M, Mazor R, Chezar J, Shapiro G, Hassan K, Shkolnik G, Geron R and Kristal B 2005 Primed peripheral polymorphonuclear leukocyte: a culprit underlying chronic low-grade inflammation and systemic oxidative stress in chronic kidney disease J. Am. Soc. Nephrol. 16 2431-8
37. Handelman G J et al 2003 Breath ethane in dialysis patients and control subjects Free Radic. Biol. Med. 35 17-23
38. Jacobs A A Jr, Ward R A, Wellhausen S R and McLeish K R 1989 Polymorphonuclear leukocyte function during hemodialysis: relationship to complement activation Nephron 52 119-24
39. Rao M, Guo D, Jaber B L, Sundaram S, Cendoroglo M, King A J, Pereira B J and Balakrishnan V S 2004 Dialyzer membrane type and reuse practice influence polymorphonuclear leukocyte function in hemodialysis patients Kidney Int. 65 682-91
40. Harris S E, Deary I J, Macintyre A, Lamb K J, Radhakrishnan K, Starr J M, Whalley L J and Shiels P G 2006 The association between telomere length, physical health, cognitive ageing and mortality in non-demented older people Neurosci. Lett. 406 260-4
41. Sklavounou E, Hay A, Ashraf N, Lamb K, Brown E, Mac I A, George W D, Hartley R C and Shiels P G 2006 The use of telomere biology to identify and develop superior nitrone based anti-oxidants Biochem. Biophys. Res. Commun. 347 420-7
42. Starr J M, McGurn B, Harris S E, Whalley L J, Deary I J and Shiels P G 2007 Association between telomere length and heart disease in a narrow age cohort of older people Exp. Gerontol. 42 571-3
43. Wright W E and Shay J W 2002 Historical claims and current interpretations of replicative aging Nat. Biotechnol. 20 682-8
44. Anding K, Gross P, Rost J M, Allgaier D and Jacobs E 2003 The influence of uraemia and haemodialysis on neutrophil phagocytosis and antimicrobial killing Nephrol. Dial. Transplant. 18 2067-73
45. Cohen G, Haag-Weber M and Horl W H 1997 Immune dysfunction in uremia Kidney Int. Suppl. 62 S79-82
46. Sardenberg C, Suassuna P, Andreoli M C, Watanabe R, Dalboni M A, Manfredi S R, dos Santos O P, Kallas E G, Draibe S A and Cendoroglo M 2006 Effects of uraemia and dialysis modality on polymorphonuclear cell apoptosis and function Nephrol. Dial. Transplant. 21 160-5
47. Sarnak M J and Jaber B L 2000 Mortality caused by sepsis in patients with end-stage renal disease compared with the general population Kidney Int. 58 1758-64
48. West I C 2000 Radicals and oxidative stress in diabetes Diabet. Med. 17 171-80
49. Yao Q, Axelsson J, Heimburger O, Stenvinkel P and Lindholm B 2004 Systemic inflammation in dialysis patients with end-stage renal disease: causes and consequences Minerva Urol. Nefrol. 56 237-48
50. Podrez E A, Abu-Soud H M and Hazen S L 2000 Myeloperoxidase-generated oxidants and atherosclerosis Free Radical Biol. Med. 28 1717-25
51. Handelman G J 2003 Efforts to determine the role of oxidant stress in dialysis outcomes Semin. Dial. 16 488-91